Phathom Pharmaceuticals(PHAT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHAT Phathom Pharmaceuticals

未开盘 02-12 16:00:00 EST

12.02

-0.21

-1.72%

盘后11.60

-0.42-3.49%

17:46 EST

最高12.41	最低11.83	成交量64.81万
今开12.38	昨收12.23	日振幅4.76%
总市值9.41亿	流通市值6.92亿	总股本7,829万
成交额779.34万	换手率1.13%	流通股本5,757万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHAT","market":"US","secType":"STK","nameCN":"Phathom Pharmaceuticals","latestPrice":12.02,"timestamp":1770930000000,"preClose":12.23,"halted":0,"volume":648116,"hourTrading":{"tag":"盘后","latestPrice":11.6,"preClose":12.02,"latestTime":"17:46 EST","volume":21277,"amount":254527.91,"timestamp":1770936360518,"change":-0.42,"changeRate":-0.034942,"amplitude":0.034942},"delay":0,"changeRate":-0.017170891251022145,"floatShares":57566899,"shares":78294775,"eps":-3.801026,"marketStatus":"未开盘","change":-0.21,"latestTime":"02-12 16:00:00 EST","open":12.38,"high":12.412,"low":11.83,"amount":7793438.704043999,"amplitude":0.047588,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.801026,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1770973200000},"marketStatusCode":0,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":12.23,"preHourTrading":{"tag":"盘前","latestPrice":12.26,"preClose":12.23,"latestTime":"08:44 EST","volume":233,"amount":2859.580108,"timestamp":1770903840046,"change":0.03,"changeRate":0.002453,"amplitude":0.009812},"postHourTrading":{"tag":"盘后","latestPrice":11.6,"preClose":12.02,"latestTime":"17:46 EST","volume":21277,"amount":254527.91,"timestamp":1770936360518,"change":-0.42,"changeRate":-0.034942,"amplitude":0.034942},"volumeRatio":0.784144,"impliedVol":1.3348,"impliedVolPercentile":0.7131},"requestUrl":"/m/hq/s/PHAT","defaultTab":"news","newsList":[{"id":"2603572114","title":"Phathom Pharmaceuticals, Inc.盘中异动 大幅跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603572114","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603572114?lang=zh_cn&edition=full","pubTime":"2026-01-12 22:45","pubTimestamp":1768229118,"startTime":"0","endTime":"0","summary":"北京时间2026年01月12日22时45分，Phathom Pharmaceuticals, Inc.股票出现波动，股价大幅跳水5.03%。截至发稿，该股报14.26美元/股，成交量25.3004万股，换手率0.32%，振幅5.00%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.00%。其相关个股中，Cdt Equity Inc C/Wts 22/09/2028、Day One Biopharmaceuticals, Inc.、Forte Biosciences, Inc.涨幅较大，Jaguar Health, Inc.、Osr Holdings, Inc.、Genprex, Inc.较为活跃，换手率分别为539.06%、111.98%、48.43%，振幅较大的相关个股有Pyxis Oncology, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Geovax Labs, Inc.，振幅分别为26.42%、25.56%、24.64%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224518a7120e9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260112224518a7120e9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"1100611774","title":"Phathom Pharmaceuticals公布1.3亿美元普通股及预先注资认股权证公开发行定价","url":"https://stock-news.laohu8.com/highlight/detail?id=1100611774","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100611774?lang=zh_cn&edition=full","pubTime":"2026-01-08 11:34","pubTimestamp":1767843258,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals今日正式宣布，已完成其普通股及预先注资认股权证公开发行的定价工作。此次发行规模总计高达1.3亿美元，标志着公司在资本市场的又一重要融资举措。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"1108691297","title":"Phathom Pharmaceuticals宣布首名患者在Eosinophilic Esophagitis (Eoe)的Voquezna® (Vonoprazan)二期研究中接受治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1108691297","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108691297?lang=zh_cn&edition=full","pubTime":"2025-11-04 21:01","pubTimestamp":1762261298,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals宣布首名患者在Eosinophilic Esophagitis (Eoe)的Voquezna® (Vonoprazan)二期研究中接受治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"1129363798","title":"Phathom Pharmaceuticals将于2025年10月30日公布2025年第三季度财务业绩及业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1129363798","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129363798?lang=zh_cn&edition=full","pubTime":"2025-10-20 20:01","pubTimestamp":1760961694,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals将于2025年10月30日公布2025年第三季度财务业绩及业务更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2575235067","title":"Phathom Pharmaceuticals, Inc.盘中异动 急速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575235067","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575235067?lang=zh_cn&edition=full","pubTime":"2025-10-14 03:32","pubTimestamp":1760383967,"startTime":"0","endTime":"0","summary":"北京时间2025年10月14日03时32分，Phathom Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.08%。截至发稿，该股报12.42美元/股，成交量65.7152万股，换手率0.93%，振幅6.18%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Compugen医疗、Nanobiotix、天境生物涨幅较大，Quoin Pharmaceuticals Ltd、Tvardi Therapeutics, Inc.、Salarius Pharmaceuticals, Inc.较为活跃，换手率分别为127.11%、63.02%、41.56%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp C/Wts 26/02/2026，振幅分别为41.90%、36.36%、34.94%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014033247a45e2bcb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251014033247a45e2bcb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2572719703","title":"Phathom Pharmaceuticals, Inc.盘中异动 快速上涨5.12%报11.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572719703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572719703?lang=zh_cn&edition=full","pubTime":"2025-09-30 22:05","pubTimestamp":1759241129,"startTime":"0","endTime":"0","summary":"北京时间2025年09月30日22时05分，Phathom Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.12%。截至发稿，该股报11.91美元/股，成交量8.575万股，换手率0.12%，振幅5.30%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Scisparc Ltd.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Anaptysbio, Inc.涨幅较大，Scisparc Ltd.、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1742.43%、285.41%、256.74%，振幅较大的相关个股有Scisparc Ltd.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Anaptysbio, Inc.，振幅分别为28.48%、26.06%、24.54%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930220529971a74b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250930220529971a74b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2558614066","title":"Phathom Pharmaceuticals, Inc.盘中异动 临近午盘股价大涨5.03%报10.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558614066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558614066?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:57","pubTimestamp":1754927856,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时57分，Phathom Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.03%。截至发稿，该股报10.23美元/股，成交量61.7348万股，换手率0.87%，振幅6.93%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为5739.85%、540.08%、183.84%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、62.69%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811235736a6dfe9b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811235736a6dfe9b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2557573683","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大涨5.21%报9.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557573683","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557573683?lang=zh_cn&edition=full","pubTime":"2025-08-08 22:50","pubTimestamp":1754664632,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日22时50分，Phathom Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.21%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Alector, Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Biovie Inc.、Onconetix, Inc.较为活跃，换手率分别为466.69%、125.32%、95.24%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Omniab Inc C/Wts ，振幅分别为73.00%、62.10%、44.44%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808225032973c0420&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808225032973c0420&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"1102423858","title":"异动解读 | Phathom Pharmaceuticals股价盘中大涨12.21%，加速核心产品推广并预期2026年盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=1102423858","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102423858?lang=zh_cn&edition=full","pubTime":"2025-08-07 22:24","pubTimestamp":1754576664,"startTime":"0","endTime":"0","summary":"周四盘中，生物制药公司Phathom Pharmaceuticals股价大幅上涨12.21%，引发市场广泛关注。这一显著涨幅与公司最新发布的积极业务前景密切相关。据悉，Phathom Pharmaceuticals近期宣布将加速其核心产品Voquezna的市场推广进程。分析人士指出，Phathom Pharmaceuticals的这一积极展望不仅反映了公司对其产品市场前景的信心，也表明公司在运营效率和成本控制方面可能取得了显著进展。此次股价大涨显示市场对公司未来发展前景持乐观态度，如果Phathom制药能够如期实现其发展目标，公司的长期增长前景将更加明朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PHAT"],"gpt_icon":1},{"id":"2557569965","title":"Phathom Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.80%报9.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557569965","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557569965?lang=zh_cn&edition=full","pubTime":"2025-08-07 21:32","pubTimestamp":1754573523,"startTime":"0","endTime":"0","summary":"北京时间2025年08月07日21时32分，Phathom Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.80%。截至发稿，该股报9.18美元/股，成交量7.4657万股，换手率0.11%，振幅1.73%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.20%。其相关个股中，Palisade Bio, Inc.、Niagen Bioscience, Inc.、Xeris制药涨幅较大，Palisade Bio, Inc.、Processa Pharmaceuticals, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为442.73%、62.38%、21.20%，振幅较大的相关个股有Lantern Pharma Inc.、Palisade Bio, Inc.、Xeris制药，振幅分别为101.17%、39.00%、12.75%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213203a47b24d4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807213203a47b24d4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"1132812036","title":"异动解读 | Phathom制药盘前大涨5.99%，加速Voquezna推广并预期2026年盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=1132812036","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132812036?lang=zh_cn&edition=full","pubTime":"2025-08-07 19:50","pubTimestamp":1754567455,"startTime":"0","endTime":"0","summary":"周四盘前交易中，生物制药公司Phathom Pharmaceuticals股价大涨5.99%，引发市场关注。据悉，Phathom制药公司近期发布了一则重要公告，表示公司有望加速其主打产品Voquezna的市场推广进程。更引人注目的是，公司预计将在2026年实现盈利，这一消息极大地提振了投资者信心。Voquezna是Phathom制药的核心产品，此次加速推广策略意味着公司正积极扩大其市场份额。分析人士认为，如果Phathom制药能够如期实现其发展目标，公司的长期增长前景将更加明朗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PHAT"],"gpt_icon":0},{"id":"1121864917","title":"异动解读 | Phathom Pharmaceuticals盘前大涨5.99%，Voquezna推广加速有望2026年实现盈利","url":"https://stock-news.laohu8.com/highlight/detail?id=1121864917","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121864917?lang=zh_cn&edition=full","pubTime":"2025-08-07 19:50","pubTimestamp":1754567446,"startTime":"0","endTime":"0","summary":"生物制药公司Phathom Pharmaceuticals今日盘前大涨5.99%，引发市场广泛关注。这一显著涨幅与公司最新发布的积极业务前景紧密相关。根据最新消息，Phathom Pharmaceuticals有望加速其重点产品Voquezna的市场推广。Voquezna作为公司的核心产品，其市场推广的加速将直接影响公司的收入增长。分析人士指出，Phathom Pharmaceuticals的这一积极展望不仅反映了公司对其产品市场前景的信心，也表明公司在运营效率和成本控制方面可能取得了显著进展。此次股价大涨显示市场对公司未来发展前景持乐观态度。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PHAT"],"gpt_icon":1},{"id":"2557788336","title":"Phathom Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.09%报8.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557788336","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557788336?lang=zh_cn&edition=full","pubTime":"2025-08-05 03:28","pubTimestamp":1754335734,"startTime":"0","endTime":"0","summary":"北京时间2025年08月05日03时28分，Phathom Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.09%。截至发稿，该股报8.78美元/股，成交量32.5216万股，换手率0.47%，振幅5.39%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.58%。其相关个股中，Psyence Biomedical Ltd.、Bioxcel Therapeutics, Inc.、凯信远达涨幅较大，Psyence Biomedical Ltd.、Soligenix, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为7439.20%、1477.41%、1052.12%，振幅较大的相关个股有凯信远达、Psyence Biomedical Ltd.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028，振幅分别为92.95%、84.21%、80.73%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080503285497338acb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080503285497338acb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT","BK4007"],"gpt_icon":0},{"id":"2555402690","title":"Phathom Pharmaceuticals, Inc.盘中异动 下午盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555402690","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555402690?lang=zh_cn&edition=full","pubTime":"2025-07-31 01:51","pubTimestamp":1753897917,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日01时51分，Phathom Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.10%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.64%。其相关个股中，Replimune Group, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Tnf Pharmaceuticals, Inc.、Salarius Pharmaceuticals, Inc.、Replimune Group, Inc.较为活跃，换手率分别为443.63%、228.48%、217.77%，振幅较大的相关个股有Replimune Group, Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为62.80%、53.86%、47.44%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731015157a6ca1577&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731015157a6ca1577&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2554770481","title":"Phathom Pharmaceuticals, Inc.盘中异动 股价大跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554770481","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554770481?lang=zh_cn&edition=full","pubTime":"2025-07-28 22:43","pubTimestamp":1753713820,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日22时43分，Phathom Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.16%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.04%。其相关个股中，Celcuity Inc.、Aim Immunotech Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Aim Immunotech Inc.、Tnf Pharmaceuticals, Inc.、Cervomed Inc.较为活跃，换手率分别为366.81%、187.45%、114.95%，振幅较大的相关个股有Aim Immunotech Inc.、Celcuity Inc.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为106.96%、82.93%、75.48%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822434197236727&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072822434197236727&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2518205329","title":"高盛：维持Phathom Pharmaceuticals(PHAT.US)评级，由中性调整至中性评级, 目标价由18.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518205329","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518205329?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:41","pubTimestamp":1741628482,"startTime":"0","endTime":"0","summary":"高盛：维持Phathom Pharmaceuticals(PHAT.US)评级，由中性调整至中性评级, 目标价由18.00美元调整至12.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11014148641581.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PHAT"],"gpt_icon":0},{"id":"2518227203","title":"Phathom Pharmaceuticals, Inc.盘中异动 快速下跌5.24%报4.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227203?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:33","pubTimestamp":1741613580,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时33分，Phathom Pharmaceuticals, Inc.股票出现异动，股价快速下挫5.24%。截至发稿，该股报4.80美元/股，成交量7.1426万股，换手率0.10%，振幅4.20%。Phathom Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2045.40%、403.94%、59.60%，振幅较大的相关个股有Akero Therapeutics, Inc.、Xencor, Inc.、Seer, Inc.，振幅分别为99.91%、99.13%、98.72%。Phathom Pharmaceuticals, Inc.公司简介：Phathom Pharmaceuticals Inc 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300abf2fcc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300abf2fcc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHAT"],"gpt_icon":0},{"id":"2518289792","title":"Phathom Pharmaceuticals, Inc.2024财年实现净利润-3.34亿美元，同比减少65.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518289792","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518289792?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536072,"startTime":"0","endTime":"0","summary":"3月10日，Phathom Pharmaceuticals, Inc.公布财报，公告显示公司2024财年净利润为-3.34亿美元，同比减少65.35%；其中营业收入为55.25百万美元，同比增加8001.17%，每股基本收益为-5.29美元。机构评级：截至2025年3月10日，当前有8家机构对Phathom Pharmaceuticals, Inc.目标价做出预测，其中目标均价为21.62美元，其中最低目标价为12.00美元，最高目标价为28.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000218abf1755d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000218abf1755d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHAT"],"gpt_icon":0},{"id":"2517152379","title":"Phathom Pharmaceuticals(PHAT.US)：2024年Q4财报实现营收2966.4万美元，前值为68.2万美元，预期值为2565万美元；每股收益为-0.79美元，前值为-0.80美元，预期值为-1.08美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517152379","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517152379?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:12","pubTimestamp":1741266750,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals(PHAT.US)：2024年Q4财报实现营收2966.4万美元，前值为68.2万美元，预期值为2565万美元；每股收益为-0.79美元，前值为-0.80美元，预期值为-1.08美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06211248574105.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PHAT"],"gpt_icon":0},{"id":"1118505333","title":"Phathom Pharmaceuticals第四季度调整后每股收益$(0.79)优于预期$(1.27)，销售额$29.66百万优于$24.91百万预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1118505333","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118505333?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:10","pubTimestamp":1741266636,"startTime":"0","endTime":"0","summary":"Phathom Pharmaceuticals报告本季度每股亏损$，超过分析师共识预期的$，提高了37.8%。这比去年同期每股亏损$增加了1.25%。这比去年同期销售额$682,000增长了4,250%。以上内容来自Benzinga Earnings专栏，原文如下：$Phathom Pharmaceuticals$  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 37.8 percent. This is a 1.25 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $29.66 million which beat the analyst consensus estimate of $24.91 million by 19.09 percent.  This is a","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Phathom Pharmaceuticals第四季度调整后每股收益$(0.79)优于预期$(1.27)，销售额$29.66百万优于$24.91百万预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PHAT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.phathompharma.com","stockEarnings":[{"period":"1week","weight":-0.0314},{"period":"1month","weight":-0.231},{"period":"3month","weight":-0.1745},{"period":"6month","weight":0.1738},{"period":"1year","weight":1.1934},{"period":"ytd","weight":-0.2755}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0139},{"period":"6month","weight":0.0588},{"period":"1year","weight":0.1291},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Phathom Pharmaceuticals, Inc.于2018年1月9日根据特拉华州法律注册成立。该公司是一家生物制药公司，专注于开发和商业化治疗胃肠道疾病或GI疾病的新疗法。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":-0.079508},{"month":2,"riseRate":0.571429,"avgChangeRate":0.060157},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.119883},{"month":4,"riseRate":0.5,"avgChangeRate":0.053339},{"month":5,"riseRate":0.5,"avgChangeRate":-0.02431},{"month":6,"riseRate":0.666667,"avgChangeRate":0.246775},{"month":7,"riseRate":0.666667,"avgChangeRate":0.025067},{"month":8,"riseRate":0.666667,"avgChangeRate":0.15186},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.003613},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.040055},{"month":11,"riseRate":0.428571,"avgChangeRate":-0.100392},{"month":12,"riseRate":0.714286,"avgChangeRate":0.070942}],"exchange":"NASDAQ","name":"Phathom Pharmaceuticals","nameEN":"Phathom Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Phathom Pharmaceuticals(PHAT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Phathom Pharmaceuticals(PHAT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Phathom Pharmaceuticals,PHAT,Phathom Pharmaceuticals股票,Phathom Pharmaceuticals股票老虎,Phathom Pharmaceuticals股票老虎国际,Phathom Pharmaceuticals行情,Phathom Pharmaceuticals股票行情,Phathom Pharmaceuticals股价,Phathom Pharmaceuticals股市,Phathom Pharmaceuticals股票价格,Phathom Pharmaceuticals股票交易,Phathom Pharmaceuticals股票购买,Phathom Pharmaceuticals股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Phathom Pharmaceuticals(PHAT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Phathom Pharmaceuticals(PHAT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}